Carpediem
Device Hematology
PDI 08051736003652
General payments
$125,157
Research payments
$258,707
Through program year 2025, $125,157 in general payments and $258,707 in research payments were reported against Carpediem (Hematology).
No combined total These are different kinds of money, reported under different rules. A meal and a clinical trial grant do not add up to anything meaningful, so this site does not add them.
By program year
10 rows| Year | Kind | Amount | Payments |
|---|---|---|---|
| 2025 | General | $55,966 | 46 |
| 2025 | Research | $10,489 | 2 |
| 2024 | General | $7,198 | 22 |
| 2024 | Research | $112,966 | 10 |
| 2023 | General | $30,210 | 33 |
| 2023 | Research | $40,470 | 9 |
| 2022 | General | $20,516 | 26 |
| 2022 | Research | $39,336 | 10 |
| 2021 | General | $11,267 | 37 |
| 2021 | Research | $55,446 | 7 |
Breakdown
The top 5 of 31 recipients; each share is of general payments naming this product in 2025.
The top 5 of 12 specialties; each share is of general payments naming this product to practitioners with a specialty in 2025. Each practitioner is counted under their primary specialty.
The top 5 of 13 states; each share is of general payments naming this product in 2025 where a state was reported.
Records
164 general · 38 researchEvery payment, record by record
Date, amount, who was paid and what for — filter by year and kind, or download as CSV, free, in files of 5,000 rows.
What you are looking at
Manufacturers name the drug, biological or device a payment relates to. CMS does not give products their own identifiers, so a product here is assembled from how it was reported — a brand may appear under more than one spelling, and this page covers one of them rather than the brand as a whole.